Cranford, NJ, United States of America

Dann Parker



Average Co-Inventor Count = 11.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Contributions of Dann Parker

Introduction

Dann Parker is a notable inventor based in Cranford, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Parker has focused on developing therapeutic agents that address critical health issues, particularly those related to the central nervous system.

Latest Patents

Among his latest patents, Parker has developed pyrimidine carboxamide compounds that serve as phosphodiesterase 2 (PDE2) inhibitors. These compounds are aimed at treating various central nervous system disorders, including schizophrenia, psychosis, Parkinson's disease, and Huntington's disease. Another significant patent involves novel nargenicin-related compounds that exhibit antibacterial properties, particularly against mycobacterial infections. This invention outlines methods for inhibiting the growth of mycobacterial cells and treating infections effectively.

Career Highlights

Parker has had a distinguished career, working with prominent companies such as Merck Sharp & Dohme Corporation and Mochida Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Parker has collaborated with talented individuals, including Qun Dang and Katherine Young. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Dann Parker's work exemplifies the impact of innovation in the pharmaceutical field. His patents not only address pressing health concerns but also highlight the importance of collaboration in scientific research. His contributions continue to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…